Wesley Yip

Assistant Professor of Urologic Oncology

City of Hope

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Research Cancer Research professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Wesley Yip is an Assistant Professor of Urologic Oncology at City of Hope in the United States. His research focuses on urologic oncology, particularly in areas such as bladder cancer, renal cell carcinoma, and upper tract urothelial carcinoma. Dr. Yip’s recent publications explore clinical predictors for lymph node involvement, perioperative considerations, and the implications of genetic variants in cancer diagnosis and treatment.

Articles (13)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (2)

Sanam Ladi Seyedian

University of Southern California

UNITED STATES

View details

Siamak Daneshmand

University of Southern California

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Wesley Yip

Research Interests

Explore related searches

Contact this professor

About

Articles (13)

Clinical and Pathological Predictors for Occult Lymph Node Involvement in Patients With Clinical Node-Negative Bladder Cancer Undergoing Radical Cystectomy

Editorial Commentary

Urothelial carcinoma: Perioperative considerations from top to bottom

Deciphering Disease Profiles in the Era of Prostate-Specific Membrane Antigen Positron Emission Tomography: Aggressive or Indolent?

Incidental Pathogenic Variants in Renal Cell and Urothelial Carcinoma: Is It Time for Universal Screening?

Wesley Yip, MD

Impact of Variant Histology on Oncological Outcomes in Upper Tract Urothelial Carcinoma: Results From the ROBUUST Collaborative Group

Final Results of a Phase I Trial of WST-11 (TOOKAD Soluble) Vascular-targeted Photodynamic Therapy for Upper Tract Urothelial Carcinoma

Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients With High-Grade Upper Tract Urothelial Carcinoma

Bladder Recurrence Following Diagnostic Ureteroscopy in Patients Undergoing Nephroureterectomy for Upper Tract Urothelial Cancer: Is Ureteral Access Sheath Protective?

Impact of Patient, Surgical, and Perioperative Factors on Discharge Disposition after Radical Cystectomy

Survival Impact of Variant Histology Diagnosis in Upper Tract Urothelial Carcinoma

An Enhanced Recovery After Surgery protocol for robotic-assisted laparoscopic nephrectomies utilizing a quadratus lumborum block

Collaborators (2)

Sanam Ladi Seyedian

Siamak Daneshmand

Make your next move.